• Profile
Close

Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease

Nephrology Dialysis Transplantation Mar 10, 2019

Chinnadurai R, et al. - In a large secondary care chronic kidney disease (CKD) cohort including 1148 patients, researchers determined the prevalence of non-alcoholic fatty liver disease (NAFLD), as well as its influence on cardiovascular and renal outcomes and mortality by using Cox regression analysis and linear regression analysis. They reported 17.9% prevalence of NAFLD. Post-scanning, participants were followed-up for a median duration of 5.4 years. The median estimated glomerular filtration rate (eGFR) was 33.5 mL/min/1.73 m2. Even an advanced CKD cohort with high comorbidity demonstrated a robust independent link between NAFLD and cardiovascular events. No association of NAFLD with all-cause mortality or CKD progression was evident. In higher risk CKD patients, routine screening for NAFLD may be warranted for cardiovascular disease (CVD) prevention.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay